Trials / Recruiting
RecruitingNCT05733585
Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair
"A Physician-initiated, Observational, Prospective, Monocentric Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair "- PuraBond Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- IRCCS San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purabond Study is a physician-initiated, observational, monocentric prospective Trial. The aim of the study is to investigate the hemostatic efficacy of PuraBond for aortic anastomoses and suture lines in patients with abdominal aortic pathology (aneurysmal or steno occlusive disease) candidate to open repair at Vascular Surgery Departement - San Raffaele Hospital (Milan, Italy). The Study will include 100 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Purabond | hemostatic efficacy of PuraBond |
Timeline
- Start date
- 2023-02-15
- Primary completion
- 2024-02-27
- Completion
- 2027-10-31
- First posted
- 2023-02-17
- Last updated
- 2026-03-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05733585. Inclusion in this directory is not an endorsement.